The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1257
ISSUE1257
March 26, 2007
Pramipexole (Mirapex) for Restless Leg Syndrome
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Pramipexole (Mirapex) for Restless Leg Syndrome
March 26, 2007 (Issue: 1257)
The dopamine agonist pramipexole (Mirapex - Boehringer Ingelheim) is the second drug approved by the FDA for treatment of moderate to severe restless legs syndrome (RLS). Ropinirole (Requip), another dopamine agonist, was approved for RLS in 2005....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.